AU2000265525A1 - Medicament for treating intestinal diseases - Google Patents

Medicament for treating intestinal diseases

Info

Publication number
AU2000265525A1
AU2000265525A1 AU2000265525A AU6552500A AU2000265525A1 AU 2000265525 A1 AU2000265525 A1 AU 2000265525A1 AU 2000265525 A AU2000265525 A AU 2000265525A AU 6552500 A AU6552500 A AU 6552500A AU 2000265525 A1 AU2000265525 A1 AU 2000265525A1
Authority
AU
Australia
Prior art keywords
medicament
intestinal diseases
treating intestinal
treating
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000265525A
Inventor
Peter Lutolf
Reto Maurer
Werner Scheiwe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mepha GmbH
Original Assignee
Mepha GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mepha GmbH filed Critical Mepha GmbH
Publication of AU2000265525A1 publication Critical patent/AU2000265525A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
AU2000265525A 2000-08-29 2000-08-29 Medicament for treating intestinal diseases Abandoned AU2000265525A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CH2000/000457 WO2002017887A1 (en) 2000-08-29 2000-08-29 Medicament for treating intestinal diseases

Publications (1)

Publication Number Publication Date
AU2000265525A1 true AU2000265525A1 (en) 2002-03-13

Family

ID=4358120

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000265525A Abandoned AU2000265525A1 (en) 2000-08-29 2000-08-29 Medicament for treating intestinal diseases

Country Status (5)

Country Link
EP (1) EP1315481B1 (en)
JP (1) JP2004507487A (en)
AU (1) AU2000265525A1 (en)
DE (1) DE50013843D1 (en)
WO (1) WO2002017887A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
WO2004062577A2 (en) * 2003-01-03 2004-07-29 Shire Laboratories Inc. Two or more enteric materials to regulate drug release
WO2004093883A2 (en) * 2003-04-23 2004-11-04 Ferring B.V. Sachet for a pharmaceutical composition
US7825106B2 (en) * 2003-09-03 2010-11-02 Agi Therapeutics Ltd. Modified release formulations and methods of treating inflammatory bowel disease
US7737133B2 (en) 2003-09-03 2010-06-15 Agi Therapeutics Ltd. Formulations and methods of treating inflammatory bowel disease
GB0419355D0 (en) * 2004-08-31 2004-09-29 Novartis Ag Organic compounds
ES2560240T5 (en) 2005-07-29 2022-11-08 Stichting Groningen Centre For Drug Res pH controlled pulsatile delivery system, methods for preparation and use thereof
SI2056675T1 (en) 2006-10-12 2019-08-30 Galera Labs, Llc Methods of treating oral mucositis
WO2013048965A1 (en) 2011-09-26 2013-04-04 Galera Therapeutics, Llc Methods for treatment of diseases
GB201202433D0 (en) 2012-02-13 2012-03-28 Diurnal Ltd Controlled drug release
US20140141075A1 (en) 2012-11-21 2014-05-22 Warner Chilcott Company, Llc 5-aminosalicylic acid capsule formulation
GB2510754B (en) * 2013-02-12 2016-07-13 Diurnal Ltd Controlled drug release
CN105307644B (en) 2013-03-15 2019-07-23 沃纳奇尔科特有限责任公司 For reducing the variational mesalazine pharmaceutical composition with a variety of dosage devices of delivering
US20210361701A1 (en) * 2017-02-15 2021-11-25 Galera Labs, Llc Pentaaza macrocyclic ring complexes for local delivery
EP3613414A1 (en) 2018-08-24 2020-02-26 Dr. Falk Pharma Gmbh Pellets with multilayer structure for delayed release of the drug in the distal colon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19732903A1 (en) * 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet formulation for the treatment of the intestinal tract
EP0943341A1 (en) * 1998-02-18 1999-09-22 Oscar Gold Procedure to prepare granulated compositions that contain erythromycin macrolides and procedure to prepare pharmaceutical compositions that contain said macrolides

Also Published As

Publication number Publication date
DE50013843D1 (en) 2007-01-18
EP1315481B1 (en) 2006-12-06
EP1315481A1 (en) 2003-06-04
JP2004507487A (en) 2004-03-11
WO2002017887A1 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
AU2001227837A1 (en) Novel treatment for eye disease
AU2001269529A1 (en) Medicine comprising dicyanopyridine derivative
IL196301A0 (en) Medicament for the treatment of hapatitis c
AU2002222853A1 (en) Therapeutic compounds
AU2001276860A1 (en) Medicaments for chemotherapeutic treatment of disease
AU2002231039A1 (en) Therapeutic stockings
AU2002343739A1 (en) Improved therapy for topical diseases
AU2000265525A1 (en) Medicament for treating intestinal diseases
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
AU2001232787A1 (en) Airway alkalinization as therapy for airway diseases
AU2000279614A1 (en) Remedies for endothelin-induced diseases
AU2000272858A1 (en) Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments
AU2001243515A1 (en) Combination drug therapy
AU2266801A (en) Combination therapy for treating neurodegenerative disease
AUPQ232599A0 (en) Drug for treating fractures
AU2001269439A1 (en) Medicinal preparations for treating sex hormone-dependent diseases
AU2002355919A1 (en) Massage apparatus for bowels
IL151188A0 (en) Medicament for viral diseases
AU1405001A (en) Treatment of diseases
AU2002210286A1 (en) Medicine intended for treatment of multiple sclerosis
AU3501100A (en) Synergistic combination for treatment of viral-mediated diseases
AU2001275696A1 (en) Therapeutic agent
AU2001271026A1 (en) Remedies for bone diseases
AU2001228863A1 (en) Remedies for ophthalmic diseases
AU2002247836A1 (en) Mycobacterrial estracts for treating autoimmune diseases